Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Toma Pakalnyte 01/04/2019 Adam Michal Sierakowski 20/05/2013 28 November 2025 The principal activity of the company during the financial year was specialist medical practice activities. 08535704 2025-03-31 08535704 bus:Director1 2025-03-31 08535704 bus:Director2 2025-03-31 08535704 2024-03-31 08535704 core:CurrentFinancialInstruments 2025-03-31 08535704 core:CurrentFinancialInstruments 2024-03-31 08535704 core:Non-currentFinancialInstruments 2025-03-31 08535704 core:Non-currentFinancialInstruments 2024-03-31 08535704 core:ShareCapital 2025-03-31 08535704 core:ShareCapital 2024-03-31 08535704 core:RetainedEarningsAccumulatedLosses 2025-03-31 08535704 core:RetainedEarningsAccumulatedLosses 2024-03-31 08535704 core:PlantMachinery 2024-03-31 08535704 core:Vehicles 2024-03-31 08535704 core:OfficeEquipment 2024-03-31 08535704 core:PlantMachinery 2025-03-31 08535704 core:Vehicles 2025-03-31 08535704 core:OfficeEquipment 2025-03-31 08535704 2024-04-01 2025-03-31 08535704 bus:FilletedAccounts 2024-04-01 2025-03-31 08535704 bus:SmallEntities 2024-04-01 2025-03-31 08535704 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08535704 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08535704 bus:Director1 2024-04-01 2025-03-31 08535704 bus:Director2 2024-04-01 2025-03-31 08535704 core:PlantMachinery core:TopRangeValue 2024-04-01 2025-03-31 08535704 core:Vehicles core:TopRangeValue 2024-04-01 2025-03-31 08535704 core:OfficeEquipment core:TopRangeValue 2024-04-01 2025-03-31 08535704 2023-04-01 2024-03-31 08535704 core:PlantMachinery 2024-04-01 2025-03-31 08535704 core:Vehicles 2024-04-01 2025-03-31 08535704 core:OfficeEquipment 2024-04-01 2025-03-31 08535704 core:CurrentFinancialInstruments 2024-04-01 2025-03-31 08535704 core:Non-currentFinancialInstruments 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 08535704 (England and Wales)

AMS PLASTIC SURGERY LTD

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

AMS PLASTIC SURGERY LTD

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

AMS PLASTIC SURGERY LTD

BALANCE SHEET

As at 31 March 2025
AMS PLASTIC SURGERY LTD

BALANCE SHEET (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 144,000 170,062
144,000 170,062
Current assets
Debtors 4 79,824 60,252
Cash at bank and in hand 36,389 65,279
116,213 125,531
Creditors: amounts falling due within one year 5 ( 111,409) ( 60,556)
Net current assets 4,804 64,975
Total assets less current liabilities 148,804 235,037
Creditors: amounts falling due after more than one year 6 ( 99,841) ( 125,662)
Provision for liabilities ( 39,130) ( 42,516)
Net assets 9,833 66,859
Capital and reserves
Called-up share capital 2 2
Profit and loss account 9,831 66,857
Total shareholders' funds 9,833 66,859

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of AMS Plastic Surgery Ltd (registered number: 08535704) were approved and authorised for issue by the Board of Directors on 28 November 2025. They were signed on its behalf by:

Adam Michal Sierakowski
Director
AMS PLASTIC SURGERY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
AMS PLASTIC SURGERY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

AMS Plastic Surgery Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 511 Galleywood Road, Chelmsford, CM2 8AA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Change in accounting estimate

The company revised the useful lives and residual values of its motor vehicles. Vehicles are now depreciated over the life of the lease (previously over 5 years) on a straight-line basis. The change reduces depreciation by £9,764 in the current year therefore increasing the carrying amount of vehicles by £9,764. The annual depreciation charge is expected to decrease by £7,080 next year compared with the previous policy.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the medical services are provided to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date. Tax is recognised in the profit and loss account, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date that are expected to apply when the timing differences reverse. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit. Deferred tax liabilities are presented within provisions for liabilities on the balance sheet.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 5 years straight line
Vehicles 3 years straight line
Office equipment 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Plant and machinery Vehicles Office equipment Total
£ £ £ £
Cost
At 01 April 2024 1,321 170,524 26,879 198,724
Additions 0 0 1,248 1,248
At 31 March 2025 1,321 170,524 28,127 199,972
Accumulated depreciation
At 01 April 2024 176 12,343 16,143 28,662
Charge for the financial year 264 24,341 2,705 27,310
At 31 March 2025 440 36,684 18,848 55,972
Net book value
At 31 March 2025 881 133,840 9,279 144,000
At 31 March 2024 1,145 158,181 10,736 170,062

4. Debtors

2025 2024
£ £
Trade debtors 33,019 32,592
Other debtors 46,805 27,660
79,824 60,252

5. Creditors: amounts falling due within one year

2025 2024
£ £
Bank loans 8,570 8,570
Trade creditors 1,215 1,290
Taxation and social security 77,761 24,082
Obligations under finance leases and hire purchase contracts (secured) 17,751 17,751
Other creditors 6,112 8,863
111,409 60,556

The hire purchase contracts are secured on vehicles of the Company with a carrying value of £133,840 (2024: £158,181).

6. Creditors: amounts falling due after more than one year

2025 2024
£ £
Bank loans 2,093 10,163
Obligations under finance leases and hire purchase contracts (secured) 97,748 115,499
99,841 125,662

The hire purchase contracts are secured on vehicles of the Company with a carrying value of £133,840 (2024: £158,181).

7. Related party transactions

Transactions with the entity's directors

Advances

At 1 April 2024 the balance owed from the directors was £4,292. During the year, the company made advances to directors amounting to £46,997 and received repayments of £4,724 leaving a balance due from the directors of £46,565.

At 1 April 2023 the balance owed from the directors was £937. During the year, the company made advances to directors amounting to £4,724 and received repayments of £1,369 leaving a balance due from the directors of £4,292.

The Directors loan account(s) are repayable on demand and interest has been charged on overdrawn balances exceeding £10,000 at the official HMRC rates.